We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SU icon
401
Suncor Energy
SU
$73B
$702K 0.05%
16,793
+628
+4% +$25.2K
LNG icon
402
Cheniere Energy
LNG
$54.3B
$701K 0.05%
2,982
+367
+14% +$86.3K
AGI icon
403
Alamos Gold
AGI
$13.7B
$700K 0.05%
20,071
-16,439
-45% -$470K
NRG icon
404
NRG Energy
NRG
$25B
$699K 0.05%
4,314
+1,571
+57% +$245K
TTWO icon
405
Take-Two Interactive
TTWO
$47B
$698K 0.05%
2,700
-3,840
-59% -$909K
ASML icon
406
ASML
ASML
$679B
$697K 0.05%
720
-180
-20% -$141K
WAY
407
Waystar Holding Corp
WAY
$4.68B
$695K 0.05%
18,334
+177
+1% +$6.56K
RCL icon
408
Royal Caribbean
RCL
$82.7B
$693K 0.05%
+2,142
New +$716K
INCY icon
409
Incyte
INCY
$24.6B
$692K 0.05%
8,159
-6,995
-46% -$553K
COR icon
410
Cencora
COR
$61.7B
$690K 0.05%
2,208
+59
+3% +$17.4K
SFM icon
411
Sprouts Farmers Market
SFM
$8.08B
$690K 0.05%
6,339
+1,374
+28% +$200K
CMC icon
412
Commercial Metals
CMC
$8.12B
$689K 0.05%
12,036
-8,459
-41% -$467K
VEEV icon
413
Veeva Systems
VEEV
$37.9B
$682K 0.05%
2,290
-405
-15% -$114K
CWEN icon
414
Clearway Energy Class C
CWEN
$6.71B
$682K 0.05%
+24,130
New +$731K
CTVA icon
415
Corteva
CTVA
$51.3B
$677K 0.05%
10,008
+4,998
+100% +$362K
ZS icon
416
Zscaler
ZS
$28.3B
$675K 0.05%
2,252
+1,553
+222% +$443K
THO icon
417
Thor Industries
THO
$4.1B
$674K 0.05%
+6,501
New +$655K
IMVT icon
418
Immunovant
IMVT
$8.12B
$672K 0.05%
+41,683
New +$675K
LKFT
419
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$669K 0.05%
19,327
+22
+0.1% +$704
GKOS icon
420
Glaukos
GKOS
$10.8B
$669K 0.05%
+8,209
New +$754K
LYFT icon
421
Lyft
LYFT
$6.53B
$668K 0.05%
30,335
+18,373
+154% +$307K
MS icon
422
Morgan Stanley
MS
$340B
$666K 0.05%
4,188
+1,176
+39% +$174K
DVY icon
423
iShares Select Dividend ETF
DVY
$23.5B
$664K 0.05%
4,672
-1,642
-26% -$227K
FNV icon
424
Franco-Nevada
FNV
$45.5B
$664K 0.05%
2,978
+398
+15% +$71.7K
ALGM icon
425
Allegro MicroSystems
ALGM
$8.11B
$664K 0.05%
+22,728
New +$735K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.